Proteomics International Pty Ltd has developed a new blood-based diagnostic test called the PromarkerEso that identifies patients with esophageal adenocarcinoma as well as patients with a pre-malignant condition called Barrett’s esophagus that can arise from chronic acid reflux.
Article: Proteomics develops new blood test for esophageal cancer